Abstract
Interest generated by the potential benefits of thrombolytic treatment (especially tissue-type plasminogen activator, t-PA) for acute stroke is tempered by the serious complication of intracranial bleeding. The risks of intracranial bleeding are presently being assessed in several United States and European pilot trials, of different design, using intravenously administered t-PA in acute stroke. Serious intracranial bleeding in these studies refers to bleeding which causes clinical neurologic deterioration not attributable to the original stroke. When the pilot phase of these investigations is complete, control groups of untreated patients will help us compare, in a scientific fashion, intracranial bleeding associated with t-PA. Meanwhile, observations on the natural incidence and clinical computed tomography (CT) features of hemorrhagic transformation (HT) in untreated patients with acute embolic stroke will have to serve as a framework for comparison with acute stroke patients treated with thrombolytic agents.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brott T, Haley C, Levy D, Barsan W, Sheppard G, Broderick J, Reed R, Marler J (1990) Safety and potential efficacy of tissue plasminogen activator (t-PA) for stroke. Stroke 21:181
Cerebral Embolism Study Group (1984) Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Stroke 15:779–789
Del Zoppo GJ, Ferbert A, Otis S, Bruckmann B, Hacke W, Zyroff J, Harker LA, Zeumer H (1988) Local intra arterial fibrinolytic therapy in acute carotid territory stroke. Stroke 19:307–313
Fisher CM, Adams RD (1951) Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol 10:92–94
Fisher CM, Adams RD (1987) Observations on brain embolism with special reference to hemorrhagic infarction. In: Furlan AJ (ed) The heart and stroke. Springer, Berlin Heidelberg New York, pp 17–36
Fisher M, Zito JL, Siva A, DeGirolami U (1984) Hemorrhagic infarction: a clinical and CT study. Stroke 15:192
Hacke W, Zeumer H, Ferbert A, Bruckmann H, Del Zoppo GJ (1988) Intra arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19:1216–1222
Hart RG, for Cerebral Embolism Study Group (1986) Timing of hemorrhagic transformation of cardioembolic stroke. In: Stober T, Schimrigk K, Ganten D, Sherman DG (eds) Central nervous system control of the heart. Nijhoff, Boston, pp 229–232
Hornig CR, Dorndorf W, Agnoli AL (1986) Hemorrhagic cerebral infarction - a prospective study. Stroke 17:179–185
Jorgensen L, Torvik A (1969) Ischemic cerebrovascular diseases in an autopsy series, part 2. Prevalence, location, pathogenesis, and clinical course of cerebral infarcts. J Neurol Sci 9:285–320
Lodder J (1984) CT-detected hemorrhagic infarction; relation with the size of the infarct, and the presence of midline shift. Acta Neurol Scand 70:329–335
Lodder J, Krijne-Kubat B, Broekman J (1986) Cerebral hemorrhagic infarction at autopsy: cardiac embolic cause and the relationship to the cause of death. Stroke 17:626–629
Mori E, Tabuchi M, Yoshida T, Yamadori A (1988) Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 19:802–812
Okada Y, Yamaguchi T, Minematsu K, Miyashita T, Sawada T, Sadashima S, Fujishima, Omae T (1989) Hemorrhagic transformation in cerebral embolism. Stroke 20:598–603
Ott BR, Zamani A, Kleefield J, Funkenstein HH (1986) The clinical spectrum of hemorrhagic infarction. Stroke 17:630–637
Sherman DG, Hart RG, for the Cerebral Embolism Study Group (1986) Brain hemorrhage in embolic stroke. In: Stober T, Schimrigk K, Ganten D, Sherman DG (eds) Central nervous system control of the heart. Nijhoff, Boston, pp 249–253
Theron J, Courtheoux P, Casasco A, Alachkar F, Notan F, Ganem F, Maiza D (1989) Local intraarterial fibrinolysis in the carotid territory. AJNR 10:753–765
The tPA Acute Stroke Study Group (1990) An open multicenter study of the safety and efficacy of various doses of tPA in patients with acute stroke. Stroke 21:181
von Kummer R, Hutschenreuter M, Wildemann B, Hacke W (1989) Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in acute occlusions of intracranial arteries. J Cereb Blood Flow Metab 9(Suppl 1):S721
Weisberg LA (1985) Nonseptic cardiogenic cerebral embolic stroke: clinical-CT correlations. Neurology 35:896–899
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Pessin, M.S. (1991). Hemorrhagic Transformation in the Natural History of Acute Embolic Stroke. In: Hacke, W., del Zoppo, G.J., Hirschberg, M. (eds) Thrombolytic Therapy in Acute Ischemic Stroke. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76439-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-76439-4_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53680-2
Online ISBN: 978-3-642-76439-4
eBook Packages: Springer Book Archive